查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1760734

2025年肿瘤分析全球市场报告

Tumor Profiling Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年肿瘤分析市场规模将快速成长。 2029年，该市场规模将成长至164.8亿美元，复合年增长率为10.1%。预测期内的预期成长可归因于多种因素，例如液态切片技术的普及、癌症研发投入的增加、人口老化、标靶治疗的应用范围扩大以及癌症研究合作的增加。预计影响这一时期的关键趋势包括向伴随诊断的转变、多基因检测的兴起、次世代定序的创新、人工智慧 (AI) 在癌症诊断中的应用以及肿瘤分析技术的进步。

个人化医疗需求的不断增长预计将在未来几年推动肿瘤分析市场的成长。个人化医疗根据每位患者的体征量身订做医疗保健方案，与传统治疗相比，它能提供更精准的治疗、更好的疗效和更少的副作用。肿瘤分析在个人化医疗中发挥关键作用，它能识别患者肿瘤中的特定基因突变和生物标记物，从而实现标靶治疗，同时将副作用降至最低。例如，2024 年 2 月，美国个人化医疗推广组织个人化医疗联盟报告称，个人化医疗将占 2023 年新药认证的三分之一以上，这一趋势将连续第四年持续。因此，个人化医疗需求的不断增长正在推动肿瘤分析市场的扩张。

为了提高癌症治疗的准确性和效率，肿瘤分析市场的主要企业越来越注重开发先进的解决方案，包括由人工智慧 (AI) 驱动的诊断工具。 AI 包括先进的计算技术，可分析复杂的基因组、蛋白质组和临床数据，从而促进更快的诊断、个人化治疗计划和更好地监测疾病进展。例如，2025 年 1 月，专门从事人工智慧驱动的癌症诊断和治疗软体的英国公司 Panakeia Technologies LTD 推出了 PANProfiler Colon。这款人工智慧软体专门使用结肠癌组织样本的 H 和 E 染色影像来分析关键的分子生物标记物，例如微卫星不稳定性 (MSI) 和错配修復缺陷 (dMMR)。该工具可以快速准确地对肿瘤进行分子分析，这对于诊断结肠癌、识别林奇症候群和确定个人化治疗至关重要。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球肿瘤学概况 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球肿瘤分析市场：成长率分析
  • 全球肿瘤分析市场表现：规模与成长，2019-2024
  • 全球肿瘤分析市场预测：规模与成长，2024-2029 年，2034 年
  • 全球肿瘤分析总目标市场（TAM）

第六章市场区隔

  • 全球肿瘤分析市场（按技术、性能和预测）：2019-2024 年、2024-2029 年、2034 年
  • 基因组学
  • 蛋白质体学
  • 表观遗传学
  • 代谢体学
  • 全球肿瘤分析市场（按技术、性能和预测）：2019-2024 年、2024-2029 年、2034 年
  • 定序技术
  • 定量聚合酵素链锁反应（qPCR）
  • 免疫组织化学
  • 原位杂交（ISH）
  • 微阵列
  • 全球肿瘤分析市场的应用、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 个人化癌症治疗
  • 肿瘤诊断
  • 调查
  • 全球肿瘤分析市场、基因体学细分市场、类型、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 次世代定序（NGS）
  • 聚合酵素链锁反应（PCR）
  • 微阵列
  • 桑格定序
  • 全球肿瘤分析市场蛋白质体学细分市场（按类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 质谱法（MS）
  • 蛋白质微阵列
  • 免疫组织化学（IHC）
  • 西方印渍术
  • 全球肿瘤分析市场表观遗传学细分（按类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • DNA甲基化分析
  • 染色质免疫沉淀定序（ChIP-seq）
  • 组蛋白修饰分析
  • 非编码RNA分析
  • 全球肿瘤分析市场代谢体学组学细分（按类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 核磁共振（NMR）光谱
  • 气相层析法质谱法（GC-MS）
  • 液相层析法质谱法（LC-MS）
  • 毛细管电泳质谱法（CE-MS）

第七章 区域和国家分析

  • 全球肿瘤分析市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球肿瘤分析市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 肿瘤分析市场：竞争格局
  • 肿瘤分析市场：公司简介
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Sysmex Corporation
  • QIAGEN NV
  • Exact Sciences Corporation
  • Guardant Health Inc.
  • GenScript Biotech Corporation
  • NeoGenomics Inc.
  • Caris Life Sciences Inc.
  • Tempus Inc.
  • Foundation Medicine Inc.
  • NanoString Technologies Inc.
  • Personalis Inc.
  • Boreal Genomics Inc.
  • Strand Life Sciences Pvt. Ltd.
  • HTG Molecular Diagnostics Inc.
  • Lucence Health Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年肿瘤分析市场：提供新机会的国家
  • 2029年肿瘤分析市场：细分领域蕴含新机会
  • 2029年肿瘤分析市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r35611

Tumor profiling is a collection of methods used to examine and characterize the genetic and molecular characteristics of a tumor. This process helps identify specific mutations, gene expression patterns, and other molecular traits of cancer cells, providing valuable insights into the biology of the tumor. It also aids in treatment decision-making and supports the development of personalized therapies.

The primary techniques used in tumor profiling include genomics, proteomics, epigenetics, and metabolomics. Genomics involves studying the genetic material (DNA) of cancer cells to identify genetic alterations that drive tumor formation and progression. It uses technologies such as sequencing, quantitative polymerase chain reaction (qPCR), immunohistochemistry, in situ hybridization (ISH), and microarrays. These techniques are commonly applied in personalized cancer treatment, oncological diagnostics, and research.

The tumor profiling market research report is one of a series of new reports from The Business Research Company that provides tumor profiling market statistics, including tumor profiling industry global market size, regional shares, competitors with a tumor profiling market share, detailed tumor profiling market segments, market trends and opportunities, and any further data you may need to thrive in the tumor profiling industry. This tumor profiling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tumor profiling market size has grown rapidly in recent years. It will grow from $10.16 billion in 2024 to $11.21 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth observed in the historic period can be attributed to several factors, including the rising prevalence of cancer cases, growing demand for personalized medicine, increased healthcare spending, wider adoption of companion diagnostics, and heightened awareness of the importance of early cancer detection.

The tumor profiling market size is expected to see rapid growth in the next few years. It will grow to $16.48 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth anticipated during the forecast period can be attributed to factors such as the increasing adoption of liquid biopsy techniques, rising investments in cancer research and development, an aging population, the expanding use of targeted therapies, and a growing number of cancer research collaborations. Key trends expected to shape this period include a shift toward companion diagnostics, an increase in multi-gene testing, technological innovations in next-generation sequencing, the integration of artificial intelligence (AI) in cancer diagnostics, and advancements in tumor profiling technologies.

The growing demand for personalized medicine is expected to fuel the growth of the tumor profiling market in the coming years. Personalized medicine tailors healthcare treatments to the unique characteristics of each patient, offering more precise therapies with better outcomes and fewer side effects compared to traditional treatments. Tumor profiling plays a key role in personalized medicine by identifying specific genetic mutations and biomarkers in a patient's tumor, enabling targeted therapies that minimize side effects. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based organization focused on advancing personalized medicine, reported that personalized medicines accounted for over one-third of all new drug approvals in 2023, marking the fourth consecutive year of this trend. As a result, the rising demand for personalized medicine is driving the expansion of the tumor profiling market.

Leading companies in the tumor profiling market are increasingly focusing on developing advanced solutions, including artificial intelligence (AI)-powered diagnostic tools, to improve the accuracy and efficiency of cancer treatment. AI involves the use of advanced computational techniques to analyze complex genomic, proteomic, and clinical data, facilitating faster diagnoses, personalized treatment plans, and better disease progression monitoring. For example, in January 2025, Panakeia Technologies LTD, a UK-based company specializing in AI-driven software for cancer diagnosis and treatment, introduced PANProfiler Colon. This AI-powered software is specifically designed to profile key molecular biomarkers, such as microsatellite instability (MSI) and mismatch repair deficiency (dMMR), using H and E-stained images of colon cancer tissue samples. The tool allows for rapid and precise molecular profiling of tumors, which is crucial for diagnosing colorectal cancer, identifying Lynch syndrome, and guiding personalized treatment decisions.

In February 2024, Myriad Genetics Inc., a U.S.-based leader in genetic testing and precision medicine, acquired assets from Intermountain Precision Genomics (IPG) for an undisclosed amount. This acquisition bolsters Myriad's precision oncology portfolio by incorporating IPG's precise tumor test, precise liquid test, and its CLIA-certified laboratory in St. George, Utah, all aimed at advancing patient care. Intermountain Precision Genomics is a US-based division specializing in molecular diagnostics, genomic testing, and tumor profiling.

Major players in the tumor profiling market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., GenScript Biotech Corporation, NeoGenomics Inc., Caris Life Sciences Inc., Tempus Inc., Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Boreal Genomics Inc., Strand Life Sciences Pvt. Ltd., HTG Molecular Diagnostics Inc., Lucence Health Inc., and Predictive Oncology Inc.

North America was the largest region in the tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tumor profiling report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tumor profiling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tumor profiling market includes revenues earned by entities by providing services such as biomarker testing, methylation profiling, and clinical trial matching. The market value includes the value of related goods sold by the service provider or included within the service offering. The tumor profiling market also includes sales of liquid biopsy kits, immunohistochemistry (IHC) kits, and methylation profiling kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Profiling Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor profiling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor profiling ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tumor profiling market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technique: Genomics; Proteomics; Epigenetics; Metabolomics
  • 2) By Technology: Sequencing Techniques; Quantitative Polymerase Chain Reaction (qPCR); Immunohistochemistry; In Situ Hybridization (ISH); Microarray
  • 3) By Application: Personalized Cancer Medicine; Oncological Diagnostics; Research
  • Subsegments:
  • 1) By Genomics: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Microarrays; Sanger sequencing
  • 2) By Proteomics: Mass Spectrometry (MS); Protein Microarrays; Immunohistochemistry (IHC); Western Blotting
  • 3) By Epigenetics: DNA Methylation Analysis; Chromatin Immunoprecipitation Sequencing (ChIP-seq); Histone Modification Profiling; Non-Coding RNA Analysis
  • 4) By Metabolomics: Nuclear Magnetic Resonance (NMR) Spectroscopy; Gas Chromatography-Mass Spectrometry (GC-MS); Liquid Chromatography-Mass Spectrometry (LC-MS); Capillary Electrophoresis-Mass Spectrometry (CE-MS)
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Hologic Inc.; Illumina Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tumor Profiling Market Characteristics

3. Tumor Profiling Market Trends And Strategies

4. Tumor Profiling Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Tumor Profiling Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tumor Profiling PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tumor Profiling Market Growth Rate Analysis
  • 5.4. Global Tumor Profiling Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tumor Profiling Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tumor Profiling Total Addressable Market (TAM)

6. Tumor Profiling Market Segmentation

  • 6.1. Global Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genomics
  • Proteomics
  • Epigenetics
  • Metabolomics
  • 6.2. Global Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing Techniques
  • Quantitative Polymerase Chain Reaction (qPCR)
  • Immunohistochemistry
  • In Situ Hybridization (ISH)
  • Microarray
  • 6.3. Global Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Personalized Cancer Medicine
  • Oncological Diagnostics
  • Research
  • 6.4. Global Tumor Profiling Market, Sub-Segmentation Of Genomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarrays
  • Sanger sequencing
  • 6.5. Global Tumor Profiling Market, Sub-Segmentation Of Proteomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mass Spectrometry (MS)
  • Protein Microarrays
  • Immunohistochemistry (IHC)
  • Western Blotting
  • 6.6. Global Tumor Profiling Market, Sub-Segmentation Of Epigenetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • DNA Methylation Analysis
  • Chromatin Immunoprecipitation Sequencing (ChIP-seq)
  • Histone Modification Profiling
  • Non-Coding RNA Analysis
  • 6.7. Global Tumor Profiling Market, Sub-Segmentation Of Metabolomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nuclear Magnetic Resonance (NMR) Spectroscopy
  • Gas Chromatography-Mass Spectrometry (GC-MS)
  • Liquid Chromatography-Mass Spectrometry (LC-MS)
  • Capillary Electrophoresis-Mass Spectrometry (CE-MS)

7. Tumor Profiling Market Regional And Country Analysis

  • 7.1. Global Tumor Profiling Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tumor Profiling Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Profiling Market

  • 8.1. Asia-Pacific Tumor Profiling Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Profiling Market

  • 9.1. China Tumor Profiling Market Overview
  • 9.2. China Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Profiling Market

  • 10.1. India Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Profiling Market

  • 11.1. Japan Tumor Profiling Market Overview
  • 11.2. Japan Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Profiling Market

  • 12.1. Australia Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Profiling Market

  • 13.1. Indonesia Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Profiling Market

  • 14.1. South Korea Tumor Profiling Market Overview
  • 14.2. South Korea Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Profiling Market

  • 15.1. Western Europe Tumor Profiling Market Overview
  • 15.2. Western Europe Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Profiling Market

  • 16.1. UK Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Profiling Market

  • 17.1. Germany Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Profiling Market

  • 18.1. France Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Profiling Market

  • 19.1. Italy Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Profiling Market

  • 20.1. Spain Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Profiling Market

  • 21.1. Eastern Europe Tumor Profiling Market Overview
  • 21.2. Eastern Europe Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Profiling Market

  • 22.1. Russia Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Profiling Market

  • 23.1. North America Tumor Profiling Market Overview
  • 23.2. North America Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Profiling Market

  • 24.1. USA Tumor Profiling Market Overview
  • 24.2. USA Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Profiling Market

  • 25.1. Canada Tumor Profiling Market Overview
  • 25.2. Canada Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Profiling Market

  • 26.1. South America Tumor Profiling Market Overview
  • 26.2. South America Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Profiling Market

  • 27.1. Brazil Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Profiling Market

  • 28.1. Middle East Tumor Profiling Market Overview
  • 28.2. Middle East Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Profiling Market

  • 29.1. Africa Tumor Profiling Market Overview
  • 29.2. Africa Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Profiling Market Competitive Landscape And Company Profiles

  • 30.1. Tumor Profiling Market Competitive Landscape
  • 30.2. Tumor Profiling Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Profiling Market Other Major And Innovative Companies

  • 31.1. Sysmex Corporation
  • 31.2. QIAGEN N.V.
  • 31.3. Exact Sciences Corporation
  • 31.4. Guardant Health Inc.
  • 31.5. GenScript Biotech Corporation
  • 31.6. NeoGenomics Inc.
  • 31.7. Caris Life Sciences Inc.
  • 31.8. Tempus Inc.
  • 31.9. Foundation Medicine Inc.
  • 31.10. NanoString Technologies Inc.
  • 31.11. Personalis Inc.
  • 31.12. Boreal Genomics Inc.
  • 31.13. Strand Life Sciences Pvt. Ltd.
  • 31.14. HTG Molecular Diagnostics Inc.
  • 31.15. Lucence Health Inc.

32. Global Tumor Profiling Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Profiling Market

34. Recent Developments In The Tumor Profiling Market

35. Tumor Profiling Market High Potential Countries, Segments and Strategies

  • 35.1 Tumor Profiling Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tumor Profiling Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tumor Profiling Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer